Canada markets closed

OKYO Pharma Limited (OKYO)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.1900+0.0100 (+0.85%)
At close: 04:00PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
2020-03-31
Cash flows from operating activities
Net Income
-13,272
-13,272
-5,431
-3,354
-1,544
Depreciation & amortization
3.797
3.797
2.331
13.111
5.979
Stock based compensation
1,274
1,274
1,719
544.387
36.34
Change in working capital
3,946
3,946
-1,024
1,045
186.534
Accounts receivable
-
-
27.376
-2.8097
-0.543
Accounts Payable
2,964
2,964
-297.991
886.093
271.218
Other working capital
-7,701
-7,701
-5,470
-1,607
-1,202
Other non-cash items
114.991
114.991
61.721
83.005
42.845
Net cash provided by operating activites
-7,695
-7,695
-5,468
-1,600
-1,202
Cash flows from investing activities
Investments in property, plant and equipment
-5.916
-5.916
-1.669
-6.943
-
Other investing activites
-
-
-
-11.171
-132.668
Net cash used for investing activites
-5.916
-5.916
-1.669
-18.114
-132.668
Cash flows from financing activities
Debt repayment
0
0
0
-12.331
-524.139
Common stock issued
7,323
7,323
0
230.019
990.639
Other financing activites
-
-
-
1.1793
-
Net cash used privided by (used for) financing activities
9,323
9,323
2,153
7,827
963.31
Net change in cash
1,622
1,622
-3,316
6,209
-371.423
Cash at beginning of period
2,701
2,701
6,889
235.485
627.616
Cash at end of period
4,045
4,045
2,701
6,889
235.485
Free Cash Flow
Operating Cash Flow
-7,695
-7,695
-5,468
-1,600
-1,202
Capital Expenditure
-5.916
-5.916
-1.669
-6.943
-
Free Cash Flow
-7,701
-7,701
-5,470
-1,607
-1,202